Engineering cell-derived matrices with controlled 3D architectures for pathophysiological studies.

Area of Science:

• Biomaterials Science
• Cell Biology
• Tissue Engineering

Background:

• The extracellular matrix (ECM) critically regulates cellular processes through its composition and architecture.
• Native ECM properties, including mechanical, chemical, and topological cues, influence cell behavior, cytoskeleton rearrangement, and gene expression.
• Tumor progression involves ECM remodeling and anisotropic architectures that can promote cancer cell invasion.

Purpose of the Study:

• To develop an innovative in vitro model of the extracellular matrix (ECM) that replicates native structural and physicochemical properties.
• To investigate the mechanistic determinants of tumor dissemination using engineered ECMs.
• To provide a versatile technique for creating 3D matrices with controlled architectures for in vitro pathophysiological studies.

Main Methods:

• Engineering of three-dimensional (3D) matrices with controlled isotropic or anisotropic architectures.
• Utilizing microfabricated guiding templates to direct 3D ECM growth.
• Seeding sacrificial fibroblasts on templates to guide ECM formation.

Main Results:

• The engineered 3D matrices successfully recapitulated the structure, composition, and cellular phenotypes of native ECM.
• Cells cultured on the engineered matrices exhibited native-like phenotypes and morphodynamics.
• The method demonstrated the ability to create both isotropic and anisotropic ECM architectures.

Conclusions:

• This versatile technique enables the development of advanced in vitro ECM models with tunable architectures.
• These engineered ECMs can accurately mimic native tissue environments for studying complex biological processes.
• The developed method holds potential for advancing pathophysiological research and clinical applications.